The Mouse Monoclonal anti-Malondialdehyde antibody has been validated for IHC. It is suitable to detect Malondialdehyde in samples from . There is 1 publication available.
IHC: Suggested concentration is 0.5-1.0 ug/mL on paraformaldehyde fixed tissue.
Restrictions
For Research Use only
Format
Liquid
Buffer
Liquid:100 ug IgG/mL in 10 mM PBS containing 0.1 % NaN 3 and 0.1 % BSA.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Yamada, Kumazawa, Ishii, Nakayama, Itakura, Shibata, Kobayashi, Sakai, Osawa, Uchida: "Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine." in: Journal of lipid research, Vol. 42, Issue 8, pp. 1187-96, (2001) (PubMed).
Target
Malondialdehyde (MDA)
Alternative Name
Malondialdehyde / MDA
Target Type
Chemical
Background
Malondialdehyde (MDA) is one of the major aldehyde derive from lipid peroxidation. MDA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with MDA and lysine residue leads to the formation of numerous numbers of adducts, such as dihydropyridine-lysine (DHP-lysine) type derivative. This monoclonal antibody is specific for the MDA-modified protein, especially DHP-lysine type derivative.